Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
J Mol Cell Cardiol
; 62: 43-50, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23643470
Palavras-chave
BMPs; Bone morphogenetic proteins; CMs; CPCs; CPVT; Cardiac differentiation; Cardiac progenitor cells; Cardiac regeneration; Cardiomyocytes; Catecholamine polymorphic ventricular tachycardia; Cell reprogramming; DMSO; Dimethylsulfoxide; ECs; END-2; ESCs; Embryonic stem cells; Endoderm-like cell line; Endothelial cells; FGF; Fetal liver kinase-1; Fibroblast growth factor; Flk-1; G-CSF; GSI; GSK3; Glycogen synthase kinase-3; Granulocyte colony-stimulating factor; Human embryonic stem cells; Human induced pluripotent stem; Induced pluripotent stem; Induced pluripotent stem (iPS) cells; Isl1; Islet-1; JAKSTAT; Janus kinasesignal transducer and activator of transcription; LIF; Leukemia inhibitory factor; MI; Myocardial infarction; OSKM; Oct3/4, Klf-4, Sox-2, and c-Myc; SCF; SMCs; Smooth muscle cells; Stem cell factor; Stem cell therapy; TGFß; Transforming growth factor-ß; VEGF; Vascular endothelial growth factor; hESCs; hiPS; iPS; γ-Secretase inhibitor
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Regeneração
/
Células-Tronco Pluripotentes Induzidas
/
Coração
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Revista:
J Mol Cell Cardiol
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Espanha